Anthera Pharmaceuticals (ANTH)
Create an Alert
0.5605
-0.02 -2.69%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Anthera Pharmaceuticals Net Income Quarterly:
-8.913M for Dec. 31, 2012Anthera Pharmaceuticals Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -8.913M |
| Sept. 30, 2012 | -11.97M |
| June 30, 2012 | -17.60M |
| March 31, 2012 | -20.91M |
| Dec. 31, 2011 | -29.16M |
| Sept. 30, 2011 | -24.44M |
| June 30, 2011 | -23.17M |
| March 31, 2011 | -18.57M |
| Dec. 31, 2010 | -13.04M |
| Sept. 30, 2010 | -8.334M |
| June 30, 2010 | -7.936M |
| March 31, 2010 | -11.10M |
| Dec. 31, 2009 | -1.478M |
| Sept. 30, 2009 | -3.604M |
| June 30, 2009 | -3.336M |
| March 31, 2009 | -3.785M |
| Dec. 31, 2008 | -4.080M |
| Sept. 30, 2008 | -5.660M |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
ANTH Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | 1.460B |
| Pfizer | 2.75B |
| Abbott Laboratories | 544.66M |
ANTH Net Income Quarterly Rankings
| Overall |
45th percentile 9065 of 16782 |
| Sector |
37th percentile 885 of 1410 in Healthcare |
| Industry |
39th percentile 82 of 135 in Drug Manufacturers - Major |
ANTH Net Income Quarterly Range, Past 5 Years
| Minimum | -29.16M | Dec 2011 |
| Maximum | -1.478M | Dec 2009 |
| Average | -12.06M |
